Given the context-dependent role of CHD1 in prostate tumors, genes showing co-occurrence (SPOP or MAP3K7) or mutual exclusivity (ERG and PTEN) should also be considered as influence factors in these clinical studies. Here, CHD1 is linked to prostate neoplasm.